C. Jacques
- Rheumatology top 0.5%
- Osteoarthritis Treatment and Mechanisms 28
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 20
- Cancer Research top 5%
- NF-κB Signaling Pathways 5
- Equine top 5%
- Immunology and Allergy top 5%
-
- Bone Metabolism and Diseases 5
- 14-3-3 protein interactions 4
- Inflammasome and immune disorders 4
-
- Adipokines, Inflammation, and Metabolic Diseases 4
-
- Bone health and treatments 4
C. Jacques
54 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Rheumatology 1.2k
- Pharmacology 518
- Cancer Research 368
- Equine 37
- Immunology and Allergy 121
Countries citing papers authored by C. Jacques
This map shows the geographic impact of C. Jacques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Jacques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Jacques more than expected).
Fields of papers citing papers by C. Jacques
This network shows the impact of papers produced by C. Jacques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Jacques. The network helps show where C. Jacques may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Jacques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2022 | 6 | |
| 3 | 2020 | 20 | |
| 4 | 2020 | 4 | |
| 5 | 2016 | 115 | |
| 6 | 2014 | 31 | |
| 7 | 2013 | 1 | |
| 8 | 2012 | 1 | |
| 9 | 2011 | 53 | |
| 10 | 2009 | 283 | |
| 11 | Primary culture and phenotyping of murine chondrocytesbreakdown → | 2008 | 580 |
| 12 | 2007 | 52 | |
| 13 | 2006 | 71 | |
| 14 | 2006 | 33 | |
| 15 | 2006 | 143 | |
| 16 | 2005 | 1 | |
| 17 | 2000 | 50 | |
| 18 | 1997 | 41 | |
| 19 | Effect of triiodothyronine on nitric oxide production in mesangial cells and renal tubular epithelial cells. | 1996 | 5 |
| 20 | 1996 | 67 |
About C. Jacques
C. Jacques is a scholar working on Rheumatology, Pharmacology, Equine, Cancer Research and Immunology and Allergy, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (28 papers), Inflammatory mediators and NSAID effects (20 papers), NF-κB Signaling Pathways (5 papers), Bone Metabolism and Diseases (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), 14-3-3 protein interactions (4 papers), Bone health and treatments (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Rheumatology (1.2k citations), Pharmacology (518 citations), Cancer Research (368 citations), Equine (37 citations) and Immunology and Allergy (121 citations). C. Jacques has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Francis Bérenbaum, Marjolaine Gosset, Sylvie Thirion, Colette Salvat, Audrey Pigenet, Alain Sautet, Carole Bougault, Christelle Sanchez, Odile Gabay and Xavier Houard. Their work appears in journals such as Osteoarthritis and Cartilage, Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Scientific Reports and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.